Developer docs
API playgroundTry for free, no card

Search company profiles

Charité Universitätsmedizin Berlin

Full company profile

uuid0007nx8

Namestring
Charité Universitätsmedizin Berlin
Legal namestring
Charité – Universitätsmedizin Berlin
Websiteurl
charite.de
Company typeenum
Private
Founded yearint
1710
Descriptiontext

Charité – Universitätsmedizin Berlin is Germany's largest university hospital and one of Europe's oldest, founded in 1710 as a plague house outside Berlin's city walls. It operates as a public law corporation (Körperschaft des öffentlichen Rechts) and serves as a constituent medical body of both Freie Universität Berlin and Humboldt-Universität zu Berlin. The institution runs four campuses (Campus Charité Mitte, Campus Virchow-Klinikum, Campus Benjamin Franklin, and Campus Berlin Buch) and treats approximately 800,000 patients per year with a staff of more than 10,000, drawing patients and collaborators from over 100 countries. It is consistently ranked among the top 10 hospitals worldwide and the best in Germany by Newsweek.

The institution combines three pillars: clinical care, medical education, and research. Its research arm includes the Berlin Institute of Health (BIH), the Deutsches Herzzentrum der Charité (DHZC), Charité 3R for alternatives to animal research, and the BIH QUEST Center. Charité deploys third-party AI diagnostic platforms including AVIEW LCS Plus for lung cancer screening, miLab MAL for malaria detection, and LVOCheck for prehospital stroke triage. Active projects include the Korea-Germany MOTIE brain-computer interface consortium for stroke rehabilitation, the $28.5M LIVE 3D bioprinting initiative for regenerative liver tissue, and the FORTIFY Consortium on European health data sharing. Construction of the Berlin Center for Gene and Cell Therapies (BC GCT) began in 2025 in partnership with Bayer AG and BIH.

Charité's revenue model rests on two primary streams: reimbursement for patient treatments through the German statutory health insurance system (GKV) under the DRG framework, and research funding from federal and state governments, the European Union (e.g., Eurostars, Innovative Health Initiative), and organizations such as DFG, BMBF, and DZIF. International patient services, medical education programs, and industry partnerships (BIOTRONIK, Bayer, Samsung) provide secondary revenue and profile. Distribution is direct through the four Berlin campuses, with additional reach via the World Health Summit, EUHA and M8 Alliance networks, and a multi-channel communications footprint spanning web, social media, and events.

Short descriptiontext

Charité – Universitätsmedizin Berlin is Germany's largest university hospital, treating ~800,000 patients annually across four Berlin campuses while operating as a public research and teaching institution affiliated with Freie Universität Berlin and Humboldt-Universität zu Berlin.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
university hospital services, clinical patient care, biomedical research, medical education training, translational medicine
Industry3 codes
1Cardiac & Cardiothoracic Specialty Hospitals
CodeHLAFAHAAPrimaryNo
2Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryNo
3International/Medical Tourism Hospital Systems
CodeHLAFAAANPrimaryNo
NAICS code2 codes
  • General Medical and Surgical Hospitals6221
  • General Medical and Surgical Hospitals622110
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
Product category
University Hospital and Academic Medical Center Services
Revenue model2 records
1Healthcare Services Reimbursement
TypeSubscription Recurring
Description

As a university hospital, Charité operates under the German public healthcare system (GKV), receiving reimbursement for patient treatments through the statutory health insurance framework.

charite.de
2Research Funding and Grants
TypeProfessional Services
Description

Charité receives substantial research funding from federal and state government sources, European Union programs (e.g., Eurostars, Innovative Health Initiative), and organizations like DZIF, DFG, and BMBF.

charite.de
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details1 tier
1Public Healthcare System Coverage
ModelSubscriptionBilling cadenceAnnual
Notes

Services covered through statutory health insurance (GKV) and private insurance reimbursement.

charite.de
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Berlin Institute of Health (BIH)
Description

Translational research unit established as third pillar of Charité alongside hospital and medical faculty

charite.de
+3 more records
Core offering1 text field

Charité Universitätsmedizin Berlin operates Germany's largest university hospital, delivering comprehensive inpatient and outpatient medical care across four Berlin campuses (Campus Charité Mitte, Campus Virchow-Klinikum, Campus Benjamin Franklin, Campus Berlin Buch). The institution combines clinical care with biomedical research through the Berlin Institute of Health (BIH) and provides medical education as a joint faculty of Freie Universität Berlin and Humboldt-Universität zu Berlin, treating approximately 800,000 patients annually across all medical specialties.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Top 10 clinic ranking worldwide
+1 more record
Product overview1 text field

Charité Universitätsmedizin Berlin is Germany's largest university hospital operating four campuses (Charité Mitte, Virchow-Klinikum, Benjamin Franklin, Berlin Buch) with approximately 800,000 patients annually. The hospital offers comprehensive medical services across all specialties and operates as a research and teaching institution affiliated with Freie Universität Berlin and Humboldt-Universität zu Berlin. Charité has deployed several AI-powered diagnostic platforms from third-party vendors: AVIEW LCS Plus and AVIEW HUB for lung cancer screening operations, miLab MAL for malaria diagnostics, and LVOCheck for acute stroke triage. The hospital provides digital health services including video consultations and online appointment booking through its MVZ (medical care center) facilities. Research initiatives include the MOTIE BCI project for stroke rehabilitation and the BIOTRONIK partnership for digital cardiology solutions. Charité also hosts the Berlin Center for Gene and Cell Therapies under construction with Bayer AG and Berlin Institute of Health.

Product and service6 records
1Comprehensive Inpatient and Outpatient Hospital Care
CategoryHospital and Clinical Care Services
Description

Comprehensive medical services ranging from emergency medicine to highly specialized therapies, prevention, and aftercare, delivered across four campuses to approximately 800,000 patients annually under Germany's statutory health insurance system.

2Videosprechstunden (Video Consultations)
CategoryDigital Health and Telemedicine Services
Description

Online video consultation service allowing patients to book appointments independently of office hours and telephone availability through the MVZ MKG online reception.

3International Health Care Services
CategoryInternational Patient Services
Description

Specialized services for international patients from over 100 countries seeking treatment unavailable in their home country, provided through Charité's International Health Care department with multi-language support.

4Medical Education and Training Programs
CategoryMedical Education and Training
Description

Medical degree programs as the joint medical faculty of Freie Universität Berlin and Humboldt-Universität zu Berlin, continuing medical education (CME), and specialized training series such as JAGO (Jungen Akademie Gynäkologische Onkologie) for young assistant physicians.

5Charité 3R Research Facility
6Berlin Center for Gene and Cell Therapies (BC GCT)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership23 partners
1FORTIFY Consortium (34 Partners)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

34-partner public-private initiative funded by the Innovative Health Initiative and aligned with the European Health Data Space. Develops legal guidance, governance tools, and technical solutions for IP-sensitive health data sharing. Runs May 2026–April 2029.

news.ki.se
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

Research and innovation partnership focused on advancing digital and translational cardiology. Combines clinical expertise at DHZC with BIOTRONIK's cardiac devices, AI, and connected health technologies. Initial projects focus on AI-driven tools and advanced simulation environments.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Collaboration on women's health research. Bayer hosted Pharma Media Days 2026 in Berlin showcasing advances in women's health, including research from Charité showing lung cancer incidence among women in Germany has reached parity with men. Bayer also leads the Berlin Center for Gene and Cell Therapies (BC GCT) project with Charité.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-30
Description

Korea-Germany consortium for commercializing brain-computer interface (BCI) for stroke rehabilitation. 36-month project (September 2025–August 2028). Neofect leads the consortium with Charité Berlin University Hospital, Bundang Seoul National University Hospital, and Imagine.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-19
Description

Part of the Liver Immunocompetent Volumetric Engineering (LIVE) project, a $28.5M effort to create regenerative bioprinted livers using FRESH 3D bioprinting technology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-16
Description

Joint leadership with Bayer AG and Charité on the Berlin Center for Gene and Cell Therapies (BC GCT) construction project to accelerate translation of gene and cell therapies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-01
Description

Collaboration on LVOCheck point-of-care platform for large vessel occlusion stroke triage. Project conducted August 2022 to April 2026, funded by Eurostars. Clinical validation published in Frontiers in Neurology across 290 patients.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborated with ABCDx and Charité on the Eurostars-funded stroke diagnostics project.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with BIOTRONIK and Charité for digital cardiology research. Jointly funding an endowed professorship for Digital and Translational Cardiology at Charité.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Part of the Korea-Germany consortium with Neofect and Charité for BCI stroke rehabilitation technology commercialization.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Part of the Korea-Germany consortium for BCI stroke rehabilitation technology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in the LIVE project for 3D bioprinted liver tissue development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in the LIVE project for 3D bioprinted liver tissue development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in the LIVE project for 3D bioprinted liver tissue development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in the LIVE project for 3D bioprinted liver tissue development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BIH forms the third pillar of Charité alongside the hospital and Medical Faculty. Tasked with biomedical translation—converting scientific findings into applications, products, and services for patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Connected through privileged partnership with Max-Delbrück-Center in the Helmholtz Association.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Charité is a public law corporation and component of Freie Universität Berlin and Humboldt-Universität zu Berlin for medical education.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charité participates in EUHA network of leading European university hospitals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charité participates in M8 Alliance of Academic Health Centers, Universities and National Academies, supporting the World Health Summit.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Charité hosts the World Health Summit, a major international health conference.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Childhood-Haus Berlin, a facility for children who have experienced violence, is operated by Charité and funded by the World Childhood Foundation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership agreement between the Berlin Philharmonic and Charité for cultural collaboration.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Mayo Clinic is a globally recognized, large-scale academic medical center that combines clinical care, research, and education with significant international patient flow. Comparable to Charité in brand-driven patient demand, multi-campus operations, and translational research leadership, though Mayo operates under a private not-for-profit model.

2Universitätsklinikum Heidelberg
TypeDirect peer
Description

Heidelberg University Hospital is one of Germany's largest and most research-intensive university hospitals, similarly combining comprehensive patient care, biomedical research, and medical education under a public-law structure. Directly comparable to Charité as a top-tier German academic medical center competing for talent, grants, and complex cases.

3Universitätsspital Zürich
TypeDirect peer
Description

University Hospital Zurich is a leading Swiss academic medical center combining patient care, research, and teaching. Comparable to Charité in role as a publicly owned, research-intensive university hospital serving as a referral center for complex cases.

TypeBroad incumbent
Description

Mass General is Harvard Medical School's largest teaching hospital and one of the top-ranked U.S. academic medical centers. Comparable to Charité as a flagship research-intensive university hospital with broad specialty coverage and significant translational research output.

TypeOthers
Description

BIH is Charité's own translational research pillar but functions as a peer organization within the Berlin academic ecosystem. It is comparable as a translational biomedical research entity partnering with industry on drug discovery and AI-driven health tools, though it is organizationally integrated with Charité.

TypeDirect peer
Description

Karolinska University Hospital in Stockholm is one of Europe's leading academic medical centers, affiliated with Karolinska Institutet. Comparable to Charité in combining tertiary care, biomedical research, and medical training under public ownership with national/international patient reach.

TypeDirect peer
Description

LMU Klinikum is the university hospital of Ludwig-Maximilians-Universität München and another of Germany's largest academic medical centers. Comparable to Charité in scale, comprehensive specialty coverage, research output, and GKV reimbursement model.

TypeDirect peer
Description

UKE is one of Germany's largest university hospitals and a direct competitor in the German academic medical center landscape. Comparable to Charité in public ownership, comprehensive specialty coverage, GKV reimbursement model, and major research funding.

TypeRegional player
Description

Vivantes is Berlin's largest municipal hospital network and a regional peer for general/tertiary care delivery in the same metropolitan market. Comparable to Charité in serving Berlin/Brandenburg patients under the GKV system, though Vivantes is a public hospital chain focused on routine care rather than a research-intensive academic medical center.

TypeDirect peer
Description

King's College Hospital is a major London-based teaching hospital and a leading European academic medical center with strong research and specialty programs. Comparable to Charité in public ownership model, research intensity, and international patient services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Charité Universitätsmedizin Berlin

University Hospital and Academic Medical Center Servicescharite.de

Charité – Universitätsmedizin Berlin is Germany's largest university hospital, treating ~800,000 patients annually across four Berlin campuses while operating as a public research and teaching institution affiliated with Freie Universität Berlin and Humboldt-Universität zu Berlin.

What Charité Universitätsmedizin Berlin does

Charité – Universitätsmedizin Berlin is Germany's largest university hospital and one of Europe's oldest, founded in 1710 as a plague house outside Berlin's city walls. It operates as a public law corporation (Körperschaft des öffentlichen Rechts) and serves as a constituent medical body of both Freie Universität Berlin and Humboldt-Universität zu Berlin. The institution runs four campuses (Campus Charité Mitte, Campus Virchow-Klinikum, Campus Benjamin Franklin, and Campus Berlin Buch) and treats approximately 800,000 patients per year with a staff of more than 10,000, drawing patients and collaborators from over 100 countries. It is consistently ranked among the top 10 hospitals worldwide and the best in Germany by Newsweek.

The institution combines three pillars: clinical care, medical education, and research. Its research arm includes the Berlin Institute of Health (BIH), the Deutsches Herzzentrum der Charité (DHZC), Charité 3R for alternatives to animal research, and the BIH QUEST Center. Charité deploys third-party AI diagnostic platforms including AVIEW LCS Plus for lung cancer screening, miLab MAL for malaria detection, and LVOCheck for prehospital stroke triage. Active projects include the Korea-Germany MOTIE brain-computer interface consortium for stroke rehabilitation, the $28.5M LIVE 3D bioprinting initiative for regenerative liver tissue, and the FORTIFY Consortium on European health data sharing. Construction of the Berlin Center for Gene and Cell Therapies (BC GCT) began in 2025 in partnership with Bayer AG and BIH.

Charité's revenue model rests on two primary streams: reimbursement for patient treatments through the German statutory health insurance system (GKV) under the DRG framework, and research funding from federal and state governments, the European Union (e.g., Eurostars, Innovative Health Initiative), and organizations such as DFG, BMBF, and DZIF. International patient services, medical education programs, and industry partnerships (BIOTRONIK, Bayer, Samsung) provide secondary revenue and profile. Distribution is direct through the four Berlin campuses, with additional reach via the World Health Summit, EUHA and M8 Alliance networks, and a multi-channel communications footprint spanning web, social media, and events.

Charité Universitätsmedizin Berlin firmographics

Firmographics
Name
Charité Universitätsmedizin Berlin
Legal name
Charité – Universitätsmedizin Berlin
Website
https://charite.de
Company type
Private
Founded year
1710
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Charité – Universitätsmedizin Berlin is Germany's largest university hospital, treating ~800,000 patients annually across four Berlin campuses while operating as a public research and teaching institution affiliated with Freie Universität Berlin and Humboldt-Universität zu Berlin.
Ownership category
akta.pro rank

Where Charité Universitätsmedizin Berlin is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

Charité Universitätsmedizin Berlin business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Healthcare Services Reimbursement: As a university hospital, Charité operates under the German public healthcare system (GKV), receiving reimbursement for patient treatments through the statutory health insurance framework.
  2. Research Funding and Grants: Charité receives substantial research funding from federal and state government sources, European Union programs (e.g., Eurostars, Innovative Health Initiative), and organizations like DZIF, DFG, and BMBF.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPublic Healthcare System Coverage

Distribution channels4 records

Marketing channels7 records

Charité Universitätsmedizin Berlin product offering

Product offering

Core offering

Charité Universitätsmedizin Berlin operates Germany's largest university hospital, delivering comprehensive inpatient and outpatient medical care across four Berlin campuses (Campus Charité Mitte, Campus Virchow-Klinikum, Campus Benjamin Franklin, Campus Berlin Buch). The institution combines clinical care with biomedical research through the Berlin Institute of Health (BIH) and provides medical education as a joint faculty of Freie Universität Berlin and Humboldt-Universität zu Berlin, treating approximately 800,000 patients annually across all medical specialties.

Product overview

Charité Universitätsmedizin Berlin is Germany's largest university hospital operating four campuses (Charité Mitte, Virchow-Klinikum, Benjamin Franklin, Berlin Buch) with approximately 800,000 patients annually. The hospital offers comprehensive medical services across all specialties and operates as a research and teaching institution affiliated with Freie Universität Berlin and Humboldt-Universität zu Berlin. Charité has deployed several AI-powered diagnostic platforms from third-party vendors: AVIEW LCS Plus and AVIEW HUB for lung cancer screening operations, miLab MAL for malaria diagnostics, and LVOCheck for acute stroke triage. The hospital provides digital health services including video consultations and online appointment booking through its MVZ (medical care center) facilities. Research initiatives include the MOTIE BCI project for stroke rehabilitation and the BIOTRONIK partnership for digital cardiology solutions. Charité also hosts the Berlin Center for Gene and Cell Therapies under construction with Bayer AG and Berlin Institute of Health.

Differentiator

Problem solved

Functional benefit

Brands

  • Berlin Institute of Health (BIH): Translational research unit established as third pillar of Charité alongside hospital and medical faculty
  • Deutsches Herzzentrum der Charité (DHZC)
  • Charité 3R
  • BIH QUEST Center

Products and services

  • Comprehensive Inpatient and Outpatient Hospital Care Comprehensive medical services ranging from emergency medicine to highly specialized therapies, prevention, and aftercare, delivered across four campuses to approximately 800,000 patients annually under Germany's statutory health insurance system.
  • Videosprechstunden (Video Consultations) Online video consultation service allowing patients to book appointments independently of office hours and telephone availability through the MVZ MKG online reception.
  • International Health Care Services Specialized services for international patients from over 100 countries seeking treatment unavailable in their home country, provided through Charité's International Health Care department with multi-language support.
  • Medical Education and Training Programs Medical degree programs as the joint medical faculty of Freie Universität Berlin and Humboldt-Universität zu Berlin, continuing medical education (CME), and specialized training series such as JAGO (Jungen Akademie Gynäkologische Onkologie) for young assistant physicians.
  • Charité 3R Research Facility
  • Berlin Center for Gene and Cell Therapies (BC GCT)

Quantifiable outcome

  • Top 10 clinic ranking worldwide
  • +1 more outcomes

Companies that use Charité Universitätsmedizin Berlin

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Charité Universitätsmedizin Berlin technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Charité Universitätsmedizin Berlin partnerships and signals

Strategic signal

Partnerships

23 partnerships are on record, tiered minor and core.

  • FORTIFY Consortium (34 Partners)minorStrategic or Co-development Partner · 2 June 202634-partner public-private initiative funded by the Innovative Health Initiative and aligned with the European Health Data Space. Develops legal guidance, governance tools, and technical solutions for IP-sensitive health data sharing. Runs May 2026–April 2029.
  • BIOTRONIKcoreStrategic or Co-development Partner · 19 May 2026Research and innovation partnership focused on advancing digital and translational cardiology. Combines clinical expertise at DHZC with BIOTRONIK's cardiac devices, AI, and connected health technologies. Initial projects focus on AI-driven tools and advanced simulation environments.
  • Bayer AGcoreStrategic or Co-development Partner · 1 April 2026Collaboration on women's health research. Bayer hosted Pharma Media Days 2026 in Berlin showcasing advances in women's health, including research from Charité showing lung cancer incidence among women in Germany has reached parity with men. Bayer also leads the Berlin Center for Gene and Cell Therapies (BC GCT) project with Charité.
  • NeofectminorStrategic or Co-development Partner · 30 January 2026Korea-Germany consortium for commercializing brain-computer interface (BCI) for stroke rehabilitation. 36-month project (September 2025–August 2028). Neofect leads the consortium with Charité Berlin University Hospital, Bundang Seoul National University Hospital, and Imagine.
  • Carnegie Mellon UniversityminorStrategic or Co-development Partner · 19 January 2026Part of the Liver Immunocompetent Volumetric Engineering (LIVE) project, a $28.5M effort to create regenerative bioprinted livers using FRESH 3D bioprinting technology.
  • Berlin Institute of HealthcoreStrategic or Co-development Partner · 16 September 2025Joint leadership with Bayer AG and Charité on the Berlin Center for Gene and Cell Therapies (BC GCT) construction project to accelerate translation of gene and cell therapies.
  • ABCDxcoreStrategic or Co-development Partner · 1 August 2022Collaboration on LVOCheck point-of-care platform for large vessel occlusion stroke triage. Project conducted August 2022 to April 2026, funded by Eurostars. Clinical validation published in Frontiers in Neurology across 290 patients.
  • FZMB GmbHminorStrategic or Co-development PartnerCollaborated with ABCDx and Charité on the Eurostars-funded stroke diagnostics project.
  • German Heart Center Foundation (DHZC)coreStrategic or Co-development PartnerPartnership with BIOTRONIK and Charité for digital cardiology research. Jointly funding an endowed professorship for Digital and Translational Cardiology at Charité.
  • Bundang Seoul National University HospitalminorStrategic or Co-development PartnerPart of the Korea-Germany consortium with Neofect and Charité for BCI stroke rehabilitation technology commercialization.
  • ImagineminorStrategic or Co-development PartnerPart of the Korea-Germany consortium for BCI stroke rehabilitation technology.
  • University of WashingtonminorStrategic or Co-development PartnerPartner in the LIVE project for 3D bioprinted liver tissue development.
  • Iowa State UniversityminorStrategic or Co-development PartnerPartner in the LIVE project for 3D bioprinted liver tissue development.
  • Mayo ClinicminorStrategic or Co-development PartnerPartner in the LIVE project for 3D bioprinted liver tissue development.
  • University of PittsburghminorStrategic or Co-development PartnerPartner in the LIVE project for 3D bioprinted liver tissue development.
  • Berlin Institute of Health (BIH)coreStrategic or Co-development PartnerBIH forms the third pillar of Charité alongside the hospital and Medical Faculty. Tasked with biomedical translation—converting scientific findings into applications, products, and services for patients.
  • Max-Delbrück-Centrum für Molekulare MedizincoreStrategic or Co-development PartnerConnected through privileged partnership with Max-Delbrück-Center in the Helmholtz Association.
  • Freie Universität Berlin and Humboldt-Universität zu BerlincoreStrategic or Co-development PartnerCharité is a public law corporation and component of Freie Universität Berlin and Humboldt-Universität zu Berlin for medical education.
  • European University Hospital Alliance (EUHA)minorStrategic or Co-development PartnerCharité participates in EUHA network of leading European university hospitals.
  • M8 AllianceminorStrategic or Co-development PartnerCharité participates in M8 Alliance of Academic Health Centers, Universities and National Academies, supporting the World Health Summit.
  • World Health SummitcoreStrategic or Co-development PartnerCharité hosts the World Health Summit, a major international health conference.
  • World Childhood FoundationminorStrategic or Co-development PartnerChildhood-Haus Berlin, a facility for children who have experienced violence, is operated by Charité and funded by the World Childhood Foundation.
  • Berliner PhilharmonikerminorStrategic or Co-development PartnerPartnership agreement between the Berlin Philharmonic and Charité for cultural collaboration.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Charité Universitätsmedizin Berlin competitors and assessment

Company assessment

Broad incumbents

  • Mayo Clinic: Mayo Clinic is a globally recognized, large-scale academic medical center that combines clinical care, research, and education with significant international patient flow. Comparable to Charité in brand-driven patient demand, multi-campus operations, and translational research leadership, though Mayo operates under a private not-for-profit model.
  • Massachusetts General Hospital: Mass General is Harvard Medical School's largest teaching hospital and one of the top-ranked U.S. academic medical centers. Comparable to Charité as a flagship research-intensive university hospital with broad specialty coverage and significant translational research output.

Direct peers

  • Universitätsklinikum Heidelberg: Heidelberg University Hospital is one of Germany's largest and most research-intensive university hospitals, similarly combining comprehensive patient care, biomedical research, and medical education under a public-law structure. Directly comparable to Charité as a top-tier German academic medical center competing for talent, grants, and complex cases.
  • Universitätsspital Zürich: University Hospital Zurich is a leading Swiss academic medical center combining patient care, research, and teaching. Comparable to Charité in role as a publicly owned, research-intensive university hospital serving as a referral center for complex cases.
  • Karolinska University Hospital: Karolinska University Hospital in Stockholm is one of Europe's leading academic medical centers, affiliated with Karolinska Institutet. Comparable to Charité in combining tertiary care, biomedical research, and medical training under public ownership with national/international patient reach.
  • LMU Klinikum München: LMU Klinikum is the university hospital of Ludwig-Maximilians-Universität München and another of Germany's largest academic medical centers. Comparable to Charité in scale, comprehensive specialty coverage, research output, and GKV reimbursement model.
  • Universitätsklinikum Hamburg-Eppendorf (UKE): UKE is one of Germany's largest university hospitals and a direct competitor in the German academic medical center landscape. Comparable to Charité in public ownership, comprehensive specialty coverage, GKV reimbursement model, and major research funding.
  • King's College Hospital NHS Foundation Trust: King's College Hospital is a major London-based teaching hospital and a leading European academic medical center with strong research and specialty programs. Comparable to Charité in public ownership model, research intensity, and international patient services.

Others

  • Berlin Institute of Health (BIH): BIH is Charité's own translational research pillar but functions as a peer organization within the Berlin academic ecosystem. It is comparable as a translational biomedical research entity partnering with industry on drug discovery and AI-driven health tools, though it is organizationally integrated with Charité.

Regional players

  • Vivantes – Netzwerk für Gesundheit GmbH: Vivantes is Berlin's largest municipal hospital network and a regional peer for general/tertiary care delivery in the same metropolitan market. Comparable to Charité in serving Berlin/Brandenburg patients under the GKV system, though Vivantes is a public hospital chain focused on routine care rather than a research-intensive academic medical center.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Charité Universitätsmedizin Berlin social profiles

Digital presence

Charité Universitätsmedizin Berlin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Charité Universitätsmedizin Berlin leadership team

Management profile

Number of profiles

Profiles12 records

Charité Universitätsmedizin Berlin funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Charité Universitätsmedizin Berlin M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Charité Universitätsmedizin Berlin

What does Charité Universitätsmedizin Berlin do?

Charité Universitätsmedizin Berlin operates Germany's largest university hospital, delivering comprehensive inpatient and outpatient medical care across four Berlin campuses (Campus Charité Mitte, Campus Virchow-Klinikum, Campus Benjamin Franklin, Campus Berlin Buch). The institution combines clinical care with biomedical research through the Berlin Institute of Health (BIH) and provides medical education as a joint faculty of Freie Universität Berlin and Humboldt-Universität zu Berlin, treating approximately 800,000 patients annually across all medical specialties.

Is Charité Universitätsmedizin Berlin a public or private company?

Charité Universitätsmedizin Berlin is a private company. It is classified as state government owned and is currently operating.

When was Charité Universitätsmedizin Berlin founded?

Charité Universitätsmedizin Berlin was founded in 1710. It employs 5,001 to 10,000 people.

Where is Charité Universitätsmedizin Berlin based?

Charité Universitätsmedizin Berlin is headquartered in Berlin, Germany, in the Europe region.

How does Charité Universitätsmedizin Berlin make money?

Two revenue lines are on record. Healthcare Services Reimbursement is the primary driver. The others are research Funding and Grants.

Who are Charité Universitätsmedizin Berlin's main competitors?

Broad incumbents on record are Mayo Clinic and Massachusetts General Hospital. Direct peers are Universitätsklinikum Heidelberg, Universitätsspital Zürich, Karolinska University Hospital, LMU Klinikum München, Universitätsklinikum Hamburg-Eppendorf (UKE) and King's College Hospital NHS Foundation Trust. Berlin Institute of Health (BIH) is listed as an others. Vivantes – Netzwerk für Gesundheit GmbH is listed as a regional player.

Does Charité Universitätsmedizin Berlin have an API?

No public API is recorded for Charité Universitätsmedizin Berlin.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Deccan HeraldSweetener used in jam, chewing gum, toothpaste linked stroke & heart attackA 30-year study of 17,710 people found that using xylitol as a sugar replacement increased the risk of blood clots, heart attacks, and strokes. The study, conducted at Berlin's Charité Medical School and Hospital, was presented at the European Society of Cardiology congress in Munich.The IndependentSweetener used in Jam may be linked to increased strokes and heart attacksResearchers from Charit\u00e9 University Hospital in Berlin presented findings at the European Society of Cardiology congress in Munich linking higher blood levels of xylitol, an artificial sweetener used in jam, gum and toothpaste, to greater cardiovascular risk. The study of 17,710 participants over six years found the highest xylitol group had a 57 per cent higher risk of major cardiovascular events than the lowest.News-MedicalCAR T-cell therapy successfully reverses severe rheumatoid arthritisResearchers at Charité – Universitätsmedizin Berlin reported in Nature Medicine on the world's first clinical trial of CD19 CAR T-cell therapy for treatment-refractory rheumatoid arthritis, involving six patients aged 31 to 69. Disease activity fell markedly in all participants, and three achieved sustained remission without medication over up to one year. A second phase with ten additional patients will compare the therapy with an approved B-cell-targeting drug.Mirage NewsCell Therapy Triumphs in Severe Rheumatoid ArthritisResearchers at Charité – Universitätsmedizin Berlin reported in Nature Medicine that six patients with treatment-refractory rheumatoid arthritis received a CD19 CAR T-cell therapy in the first phase of the COMPARE trial, with disease activity falling in all participants. By one year, three patients were in sustained remission without medication, and autoantibody levels declined sharply. A second phase with ten additional patients will compare the therapy to an approved B-cell-targeting drug.FAZ.NETCharité vs. Querdenker: OVG stärkt WissenschaftsfreiheitA guest post by Klaus Ferdinand Gerditz, dated 27 August 2026, reports that the Oberverwaltungsgericht (OVG) ruled in favor of the Charité in Berlin, protecting the hospital from requests by "Querdenker" activists. The article states the judgment draws limits on information requests and places scientific freedom above disclosure claims. No further details of the ruling are given.FolhaEclipse solar leva dezenas a hospitais na AlemanhaDozens of patients sought medical attention in Germany following the solar eclipse due to eye pain and visual disturbances caused by unprotected observation. Major hospitals in Berlin, such as Charité and Vivantes, along with facilities in Baden-Württemberg, reported treating approximately 60 individuals for symptoms ranging from headaches to potential retinal injuries. While current symptoms are described as mild with no permanent damage detected yet, officials warn that cases may increase over the coming days.GoogleCan THC Quiet PTSD Nightmares? New Research Offers CluesA randomized, double-blind, placebo-controlled trial led by Charité – Universitätsmedizin Berlin in Germany found that dronabinol, a pharmaceutical THC oral solution, significantly reduced trauma-related nightmares in 171 adults with PTSD over ten weeks. Nightmares disappeared in more than a third of treated patients, with an average nightmare burden score drop of 3.7 versus 2.2 in the placebo group. Researchers found no significant improvement in overall PTSD severity or depression.ExameParkinson: cientistas descobrem 'ritmo oculto' do cérebro que pode melhorar tratamentoResearchers from the University of Cologne, Harvard Medical School, and Charité Berlin identified a specific brain network rhythm between 20 and 35 Hz that correlates with improved motor symptoms in Parkinson's patients undergoing deep brain stimulation. This discovery, published in the journal Brain, reveals that stronger communication within this neural network leads to greater therapeutic benefits, offering a pathway for more precise treatment adjustments. The findings may enable doctors to personalize stimulation settings for patients who do not currently achieve desired symptom relief.FAZ.NETWie viel Schlaf brauchen wir wirklich?The article discusses individual variations in sleep needs and skepticism toward smartwatch tracking, while highlighting a study by Charité Berlin on heart risks for female endurance athletes. It also reports that insurance group Allianz achieved an operational record profit of 9.4 billion euros in the first half of 2026 despite implementing AI-driven automation that may lead to job cuts.SciTechDailyA Cannabis-Based Drug Dramatically Reduced PTSD NightmaresResearchers at Charité – Universitätsmedizin Berlin conducted a double-blind trial demonstrating that Dronabinol, a prescription THC medication, significantly reduced PTSD-related nightmares in over 170 participants. The study reported that more than one-third of patients experienced complete disappearance of nightmares, with the treatment group showing greater symptom reduction compared to placebo. The research was supported by an unrestricted grant and provided with study medication by Bionorica SE.